Search Page

1

Cite

Share

Effects of ω-3 fatty acids on cognitive performance: a meta-analysis.

Mazereeuw G, Lanctôt KL, Chau SA, Swardfager W, Herrmann N. Mazereeuw G, et al. Among authors: herrmann n. Neurobiol Aging. 2012 Jul;33(7):1482.e17-29. doi: 10.1016/j.neurobiolaging.2011.12.014. Epub 2012 Feb 3. Neurobiol Aging. 2012. PMID: 22305186

Cite

Share

2

Cite

Share

A correlation between cognitive performance and daily functioning in elderly people.

Warren EJ, Grek A, Conn D, Herrmann N, Icyk E, Kohl J, Silberfeld M. Warren EJ, et al. Among authors: herrmann n. J Geriatr Psychiatry Neurol. 1989 Apr-Jun;2(2):96-100. doi: 10.1177/089198878900200209. J Geriatr Psychiatry Neurol. 1989. PMID: 2775443

Cite

Share

3

Cite

Share

Recent advances in geriatric psychopharmacology.

Naranjo CA, Herrmann N, Mittmann N, Bremner KE. Naranjo CA, et al. Among authors: herrmann n. Drugs Aging. 1995 Sep;7(3):184-202. doi: 10.2165/00002512-199507030-00004. Drugs Aging. 1995. PMID: 8535049 Review.

Cite

Share

4

Cite

Share

Pharmacotherapy of late life mood disorders.

Herrmann N, Bremner KE, Naranjo CA. Herrmann N, et al. Clin Neurosci. 1997;4(1):41-7. Clin Neurosci. 1997. PMID: 9056122 Review.

Cite

Share

5

Cite

Share

From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.

Herrmann N, Lanctôt KL. Herrmann N, et al. Can J Psychiatry. 1997 Jun;42 Suppl 1:51S-64S. Can J Psychiatry. 1997. PMID: 9220129 Review.

Cite

Share

6

Cite

Share

Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo.

Ozdemir V, Naranjo CA, Herrmann N, Reed K, Sellers EM, Kalow W. Ozdemir V, et al. Among authors: herrmann n. Clin Pharmacol Ther. 1997 Sep;62(3):334-47. doi: 10.1016/S0009-9236(97)90037-0. Clin Pharmacol Ther. 1997. PMID: 9333110 Clinical Trial.

Cite

Share

7

Cite

Share

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis.

Mittmann N, Herrmann N, Einarson TR, Busto UE, Lanctôt KL, Liu BA, Shulman KI, Silver IL, Narango CA, Shear NH. Mittmann N, et al. Among authors: herrmann n. J Affect Disord. 1997 Dec;46(3):191-217. doi: 10.1016/s0165-0327(97)00107-9. J Affect Disord. 1997. PMID: 9547117

Cite

Share

8

Cite

Share

The use of clock tests in schizophrenia.

Herrmann N, Kidron D, Shulman KI, Kaplan E, Binns M, Soni J, Leach L, Freedman M. Herrmann N, et al. Gen Hosp Psychiatry. 1999 Jan-Feb;21(1):70-3. doi: 10.1016/s0163-8343(98)00066-8. Gen Hosp Psychiatry. 1999. PMID: 10068923

Cite

Share

9

Cite

Share

Clock tests in depression, Alzheimer's disease, and elderly controls.

Herrmann N, Kidron D, Shulman KI, Kaplan E, Binns M, Leach L, Freedman M. Herrmann N, et al. Int J Psychiatry Med. 1998;28(4):437-47. doi: 10.2190/5QA5-PHUN-1Q9F-C0PB. Int J Psychiatry Med. 1998. PMID: 10207742

Cite

Share

10

Cite

Share

Bipolar disorder in old age.

Shulman KI, Herrmann N. Shulman KI, et al. Among authors: herrmann n. Can Fam Physician. 1999 May;45:1229-37. Can Fam Physician. 1999. PMID: 10349067 Free PMC article. Review.

Cite

Share